Cassava Rockets After SEC Reportedly Clears It Of Tampering
403
SAVA:NASDAQ is one of those stocks that can get super spikey on news and after a 10 month investigation the SEC has apparently cleared them of any wrongdoing after having previously accused the company of manipulating research results of its experimental Alzheimers Disease drug.
Feels overbought at the moment looking at the RSI, but could be one to watch.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.